Prostate Cancer - Results from #28220

Are we able to correctly identify prostate cancer patients who could be adequately treated by focal therapy? - Abstract April 25, 2011

Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer - Abstract April 25, 2011

Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial - Abstract April 25, 2011

Full functional-length urethral sphincter preservation during radical prostatectomy - Abstract April 25, 2011

Editor's Commentary - ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program April 25, 2011

An analysis of world media reporting of two recent large randomized prospective trials investigating screening for prostate cancer - Abstract April 22, 2011

No evidence of XMRV or related retroviruses in a London HIV-1-positive patient cohort - Abstract April 22, 2011

Quality assurance of U.S.-guided external beam radiotherapy for prostate cancer: Report of AAPM Task Group 154 - Abstract April 22, 2011

A compact mechatronic system for 3D ultrasound guided prostate interventions - Abstract April 22, 2011

Effect of statin use on biochemical outcome following radical prostatectomy - Abstract April 22, 2011

Nanotechnologies to use bisphosphonates as potent anticancer agents: The effects of zoledronic acid encapsulated into liposomes - Abstract April 22, 2011

Differences in sleep disturbance and fatigue between patients with breast and prostate cancer at the initiation of radiation therapy - Abstract April 22, 2011

Contemporary management of metastatic castration-resistant prostate cancer - Abstract April 22, 2011

Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer - Abstract April 22, 2011

EAU 2011 - Phase III study of intermittent MAB vs. continuous MAB - Session Highlights April 22, 2011

EAU 2011 - Risk patterns of fractures and cardiovascular and thromboembolic disease, following prostate cancer treatment: Results from the population-based PCBaSe Sweden - Session Highlights April 22, 2011

Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence - Abstract April 21, 2011

Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy - Abstract April 21, 2011

Cardiovascular risk during hormonal treatment in patients with prostate cancer - Abstract April 21, 2011

Cabazitaxel: A novel second-line treatment for metastatic castration-resistant prostate cancer - Abstract April 21, 2011

Page 1412 of 1438